Michael J. Fox Foundation
Michael J. Fox Foundation is dedicated to finding better treatments and cure for Parkinson’s disease.
Business Model: B2C Non-Profit
Revenue: $163.1M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Michael J. Fox Foundation Information
Geographic Data
Address: Grand Central Station
City: New York
State: NY
Zip: 10163
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
267,675Website Global Rank
236,952Website Monthly Traffic
Twitter Followers
Description
The Michael J. Fox Foundation is a trust fund and a nonprofit research firm. It focuses on finding a cure for Parkinson disease and improved therapies for those living with the condition. The firm operates through a funded and targeted research program coupled with active global engagement of scientists, Parkinson’s patients, business leaders, clinical trial participants, donors, and volunteers. The Michael J. Fox Foundation was founded by Deborah Brooks in 2000 and is headquartered in New York.
Contact Phone:
+18007087644
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2013 | ZelosDx | Grant | 250k |
| 7/2022 | EpicentRx Inc | Grant | 0 |
| 8/2022 | Seelos Therapeutics | Grant | - |
| 11/2020 | Caraway Therapeutics | Grant | - |
| 6/2022 | Alzprotect | Grant | 338k |
| 3/2017 | Inhibikase Therapeutics | Grant | 433k |
| 6/2019 | Nitrase Therapeutics | Grant | - |
| 12/2021 | Arkuda Therapeutics | Grant | - |
| 3/2020 | Lundbeck | Grant | - |
| 2/2023 | Newel Health | Grant | 2.5M |
| 2/2020 | Olaris | Grant | - |
| 1/2018 | Neuropore Therapies | Grant | - |
| 9/2013 | Motus Therapeutics | Grant | 1.4M |
| 12/2010 | Amicus Therapeutics | Grant | 500k |
| 10/2016 | Asceneuron | Grant | - |
| 5/2012 | Envoy Therapeutics | Grant | 1.2M |
| 9/2014 | nLife Therapeutics | Grant | 350k |
| 3/2013 | Addex Therapeutics | Grant | 1M |
| 10/2021 | MISSION Therapeutics | Grant | 0 |
| 2/2018 | OccamzRazor | Grant | 650k |
| 11/2022 | Esya | Grant | 452k |
| 7/2018 | Amydis | Grant | - |
| 3/2019 | Inflazome | Grant | 1M |
| 7/2022 | ZyVersa Therapeutics | Grant | - |
| 5/2022 | Asceneuron | Grant | - |
| 7/2021 | NRG Therapeutics | Grant | 0 |
| 11/2020 | MapLight Therapeutics | Grant | 8.1M |
| 5/2018 | Alkahest | Grant | - |
| 10/2022 | Amydis | Grant | 1.5M |
| 8/2020 | Amydis | Grant | - |
| 1/2009 | Omeros | Grant | 465k |
| 8/2022 | Koneksa Health | Grant | - |
| 12/2011 | Trevena | Grant | 205k |
| 10/2021 | Sinopia Biosciences | Grant | 2M |
| 1/2017 | Addex Therapeutics | Grant | 835k |
| 4/2014 | Domain Therapeutics | Grant | 230k |
| 11/2010 | Ceregene | Series D | 11.5M |
| 5/2019 | Casma Therapeutics | Grant | 370k |
| 5/2022 | Modality.AI, Inc. | Grant | 2.3M |
| 1/2017 | Neuropore Therapies | Grant | - |
| 1/2022 | ND BioSciences | Grant | - |
| 1/2020 | Sinopia Biosciences | Grant | 450k |
| 11/2011 | Sapiens Steering Brain Stimulation | Series A | 13.3M |
| 10/2022 | Muna Therapeutics | Grant | 4.9M |
| 4/2017 | MISSION Therapeutics | Grant | - |
| 6/2022 | Koneksa Health | Grant | - |
| 2/2015 | Saniona | Grant | 590.7k |
| 8/2022 | Koneksa Health | Grant | - |
| 7/2022 | ZyVersa Therapeutics | Grant | - |
| 7/2022 | EpicentRx Inc | Grant | 0 |
| 6/2022 | Koneksa Health | Grant | - |
| 6/2022 | Alzprotect | Grant | 0 |
| 5/2022 | Asceneuron | Grant | - |
| 1/2022 | ND BioSciences | Grant | - |
| 12/2021 | Arkuda Therapeutics | Grant | - |
| 10/2021 | MISSION Therapeutics | Grant | 0 |
| 7/2021 | NRG Therapeutics | Grant | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
